Medicare patients who have access to telehealth services and medications for opioid use disorder have lower risk of fatal drug overdose, according to a study reported yesterday in JAMA Psychiatry.

“The results of this study add to the growing research documenting the benefits of expanding the use of telehealth services for people with opioid use disorder, as well as the need to improve retention and access to medication treatment for opioid use disorder,” said Christopher Jones, lead author and director of the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention. “The findings from this collaborative study also highlight the importance of working across agencies to identify successful strategies to address and get ahead of the constantly evolving overdose crisis.”

Related News Articles

Headline
AHA submitted a statement May 8 to the House Ways and Means Committee for a markup session on proposed legislation impacting telehealth access for patients and…
Headline
In a letter submitted May 7 to a bipartisan group of senators, AHA urged Congress to extend the Affordable Connectivity Program, which provides benefits toward…
Headline
Sen. John Thune, R-S.D., April 16 updated AHA members on progress to extend telehealth waivers, offering hope that a solution will arise in end-of-year…
Headline
Rep. Morgan Griffith, R-Va., touted the benefits of telehealth April 15, saying it is uncovering hidden health care savings by encouraging patients to seek…
Headline
The Department of Health and Human Services’ revised “bulletin” for HIPAA covered entities and business associates using online tracking technologies only…
Headline
In a statement submitted April 10 to the House Energy and Commerce Subcommittee on Health for a hearing on legislative proposals to support patient access to…